Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Zachary S. Wallace
ResearcherPublications, citations & collaboration network
Zachary S. Wallace is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 289 works, 15,759 citations, an h-index of 57 and an i10-index of 149.
289
Works
15,759
Citations
57
h-index
149
i10-index
How has Zachary S. Wallace's publication output changed over time?
ScholarIQpublication output · 2014–2021
Output grew0% over the shown period — from 1 works in 2014 to 1 in 2021.
1
3
1
1
3
1
1
2014201520162018201920202021
What are the most-cited papers on Zachary S. Wallace?
ScholarIQmost cited works
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, Loreto Carmona, Maria I. Danila, Laure Gossec, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Saskia Lawson‐Tovey, Elsa F Mateus, Stephanie Rush, Gabriela Schmajuk, Julia F. Simard, Anja Strangfeld, Laura Trupin, Katherine D. Wysham, Suleman Bhana, Wendy Costello, Rebecca Grainger, Jonathan S. Hausmann, Jean W Liew, Emily Sirotich, Paul Sufka, Zachary S. Wallace, Jinoos Yazdany, Pedro Machado, Philip C. Robinson
Annals of the Rheumatic Diseases. 20201,181 CitationsOPEN ACCESS
International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease
Arezou Khosroshahi, Zachary S. Wallace, Jayne Littlejohn Crowe, Takashi Akamizu, Atsushi Azumi, Mollie N. Carruthers, Suresh T. Chari, Emanuel Della‐Torre, Luca Frulloni, Hiroshi Gotô, Phil A. Hart, Terumi Kamisawa, Shigeyuki Kawa, Mitsuhiro Kawano, M. H. Kim, Yuzo Kodama, Kensuke Kubota, Markus M. Lerch, Matthias Löhr, Yasufumi Masaki, Shoko Matsui, Tsuneyo Mimori, Shôji Nakamura, Takahiro Nakazawa, Hitomi Ohara, Kazuichi Okazaki, Jay H. Ryu, Takako Saeki, N. Schleinitz, Akira Shimatsu, Tooru Shimosegawa, Hiroki Takahashi, Masayuki Takahira, Atsushi Tanaka, Mark Topazian, Hisanori Umehara, George Webster, Thomas E. Witzig, Motohisa Yamamoto, Wen Zhang, T. Chiba, John H. Stone
Arthritis & Rheumatology. 20151,059 Citations
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
Zachary S. Wallace, Ray Naden, Suresh T. Chari, Hyon K. Choi, Emanuel Della‐Torre, Jean-Francois Dicaire, Phillip A. Hart, Dai Inoue, Mitsuhiro Kawano, Arezou Khosroshahi, Marco Lanzillotta, Kazuichi Okazaki, Cory A. Perugino, Amita Sharma, Takako Saeki, N. Schleinitz, Naoki Takahashi, Hisanori Umehara, Yoh Zen, John H Stone
Annals of the Rheumatic Diseases. 2019753 Citations
Rituximab for IgG4-related disease: a prospective, open-label trial
Mollie N. Carruthers, Mark Topazian, Arezou Khosroshahi, Thomas E. Witzig, Zachary S. Wallace, Philip Hart, Vikram Deshpande, Thomas C. Smyrk, Suresh T. Chari, John H. Stone
Annals of the Rheumatic Diseases. 2015714 Citations
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld, Martin Schäfer, Milena Gianfrancesco, Saskia Lawson‐Tovey, Jean W. Liew, Lotta Ljung, Elsa F Mateus, Christophe Richez, María José Santos, Gabriela Schmajuk, Carlo Alberto Scirè, Emily Sirotich, Jeffrey A. Sparks, Paul Sufka, Thierry Thomas, Laura Trupin, Zachary S. Wallace, Sarah Al-Adely, Javier Bachiller‐Corral, Suleman Bhana, P. Cacoub, Loreto Carmona, Ruth Costello, Wendy Costello, Laure Gossec, Rebecca Grainger, É. Hachulla, Rebecca Hasseli, Jonathan S. Hausmann, Kimme L Hyrich, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Lianne Kearsley‐Fleet, Philip C. Robinson, Jinoos Yazdany, Pedro Machado
Annals of the Rheumatic Diseases. 2021693 CitationsOPEN ACCESS
Related on ScholarIQ
Amgen (United States)
Institution
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Paper
International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease
Paper
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
Paper
Rituximab for IgG4-related disease: a prospective, open-label trial
Paper
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Paper